HCV. The Spectrum of Hepatitis C Virus Infection: From Acute Infection to End-Stage Liver Disease.

Slides:



Advertisements
Similar presentations
1. Interpret a positive HBeAg, Anti- HBcAg, and/or anti-HCV test.
Advertisements

The changing pattern of viral hepatitis in Saudi Arabia Yousef Qari, MD, FRCP(C), ABIM Gastoenterologist King Abdulaziz University Hospital.
Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis Branch Centers for Disease Control and Prevention An Overview.
V.E.I.L. Liver Cancer Prevention. 1. Vaccination Birth dose + 2 Universal for those not already chronics Screening pregnant women Catch up vaccination.
Hepatitis C for the General Practitioner Morris Sherman MB BCh PhD FRCP(C) University of Toronto January 2013.
Hepatitis B and C: A silent but deadly epidemic Arun J Sanyal M.D. Charles Caravati Professor of Medicine Virginia Commonwealth University Richmond, Virginia.
Module 3: HCV prevalence and course of HCV infection.
Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis D (Delta) Virus Division of Viral Hepatitis.
Sara Stevenson Hepatitis B Nurse Specialist St James’s Hospital, Leeds.
Assessing the public health challenge posed by Hepatitis B and C in the EU European Centre for Disease Prevention and Control Information for members of.
Hepatitis C A Growing Problem of Pakistan. Group Members Zoya Imran Mariam Archer Nawal Nawaz Sidra Tul Muntaha.
Mun Hyuk Seong,1 Ho Kil,1 Young Seok Kim,2 Si Hyun Bae,3 Youn Jae Lee,4 Han Chu Lee,5 Byung Hak Kang,6 and Sook-Hyang Jeong1* Clinical and Epidemiological.
Liver transplantation for HCV infection R3 양 인 호 /Prof 김 병 호.
HBV. Overview of the Epidemiology of Hepatotropic Viruses.
Viral Hepatitis.
Treatment of HBV/HCV Coinfection
What is Hep C Dave Stafford.
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Value in Health Regional Issues
Hepatitis C: Overview and Epidemiology
Dr. Mohammed Omar Khalifa
In The Name of God.
The typical course of acute and chronic hepatitis C
Volume 65, Issue 1, Pages S82-S94 (October 2016)
HCV & liver transplantation
Copyright © 2007 American Medical Association. All rights reserved.
A. Stepanov, A. Kruk, N. Polovinkina, A. Vinogradova
Serologic diagnosis of HBVinfection
Additional file 2 Total HCC cases N=39
Talking to Patients About HCV Treatment
A Review of the Critical Role of Imaging in Primary Liver Malignancy
Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.
Chronic Hepatitis C Virus Infection
Starting Strong: Initial Evaluation of the Patient With HCV
Extrahepatic Manifestations of HCV Infection
HCV: Who Should We Screen and Why?
More Than Meets the Eye: Identifying Who Is at Risk for NASH
World Epidemiology. Are HIV and Other Chronic Diseases Models Applicable to Viral Hepatitis? Focus on HCV.
The Aging Liver in the Aging HIV and HCV Patients
Number of HCV tests conducted
Case Challenges in Chronic Migraine
Figure 2 A stage-based approach to the treatment of NAFLD
More Than Treatment.
HCV Screening.
HBV Infection: Some Sobering Facts
HBV Care Models: Community Collaborations for Best Practices
Evaluation of the Patient With HCV Infection
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.
Division of Viral Hepatitis
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Value in Health Regional Issues
Virological tools to diagnose and monitor hepatitis C virus infection
Care of the Treatment-naive Patient With HCV/HIV Coinfection
HEPATITIS C BY MBBSPPT.COM
Just when you thought you knew everything.
Hepatitis C: After the Diagnosis
Managing Age-Related Clinical Issues in Hemophilia
Genomic risk of hepatitis C-related hepatocellular carcinoma
Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection  Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.
Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.
Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg 
Epidemiology of socially significant infectious diseases (TB, HIV-infection, viral hepatitis C and B) in Russia Olga Nechaeva Expert of the Expert Group.
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences  Zobair M. Younossi, Aybike Birerdinc,
Removing Barriers in the HCV Cascade of Care
NAFLD and NASH in Europe and Canada
Markov model of HCV–HCC disease process.
Managing Hepatitis C in Vermont
Reversion of disease manifestations after HCV eradication
Presentation transcript:

The Spectrum of Hepatitis C Virus Infection: From Acute Infection to End-Stage Liver Disease

HCV

HCV (cont)

Epidemiology of HCV

The Prevalence of HCV Infection in the US

The Silent Epidemic

The Paradox of HCV Infection

Percutaneous Exposure to HCV

What Else Puts Someone at Risk for HCV Infection?

Self-Limited Infection Occurs in 15% - 25% of HCV-Infected People

How Is HCV Detected?

Screening for HCV  Detection of HCV Infection

Confirmation With an HCV RNA Test is Necessary After a Positive Anti-HCV Screen

Liver Enzymes

HCV Genotypes

Natural History of HCV Infection

Cirrhosis and HCC

Consequences of ESLD

The Natural History of Chronic HCV Infection

Factors That Increase the Risk for Chronic HCV Progression

Management of the Patient With Chronic HCV Infection

Noninvasive Tests Decrease the Need for Liver Biopsy

Cirrhosis

Extrahepatic Manifestations of Chronic HCV Infection

HCV REVEAL Study

HCV REVEAL Study (cont)

Summary

Abbreviations

References

References (cont)

References (cont)

References (cont)